文献速递心外重症与机械循环支持

无全身抗凝的静脉-静脉体外膜氧合可行性研究

Feasibility of Venovenous Extracorporeal Membrane Oxygenation Without Systemic Anticoagulation.
PubMed 文献 · Ann Thorac Surg · 2020-03-12

提示无持续全身抗凝的静脉-静脉ECMO可行且可能减少出血和输血。

要点

  • 无持续全身抗凝的静脉-静脉ECMO患者生存率与抗凝组无差异。
  • 无抗凝组胃肠道出血率和氧合器功能障碍率显著低于抗凝组。
  • 无抗凝组红细胞、血浆和血小板输注率均显著更低,且无环路血栓。

核心结论

  • 静脉-静脉ECMO可不经持续全身抗凝安全实施,可能减少出血倾向和输血需求。

研究设计与样本

  • 回顾性分析单中心ECMO数据库,纳入2015年1月至2019年2月连续患者,AC+组38例,AC-组36例。

主要发现

  • 两组ECMO支持期间均无环路血栓形成。

关键数值与推荐

  • outcomes和并发症定义采用已发表的体外生命支持组织(ELSO)指南。

临床怎么用

  • 对于急性呼吸窘迫综合征接受静脉-静脉ECMO的患者,可考虑不给予持续全身抗凝,仅用标准静脉血栓预防,以降低出血和输血风险。

局限性

  • 回顾性单中心研究,样本量有限,结果需前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venovenous extracorporeal membrane oxygenation (ECMO) is increasingly being used for acute respiratory distress syndrome and as a bridge to lung transplantation. After initiation of venovenous ECMO, systemic anticoagulation therapy is traditionally administered and can cause bleeding diathesis. Here, we investigated whether venovenous ECMO can be administered without continuous systemic anticoagulation administration for patients with acute respiratory distress syndrome. METHODS: This is a retrospective review of an institutional ECMO database. We included consecutive patients from January 2015 through February 2019. Overall, 38 patients received low levels of continuous systemic anticoagulation (AC+) whereas the subsequent 36 patients received standard venous thromboprophylaxis (AC-). Published Extracorporeal Life Support Organization guidelines were used for the definition of outcomes and complications. RESULTS: Overall, survival was not different between the two groups (P = .58). However, patients in the AC+ group had higher rates of gastrointestinal bleeding (28.9%, vs AC- group 5.6%; P < .001). The events per patient-day of gastrointestinal bleeding was 0.00025 in the AC- group and 0.00064 in the AC+ group (P < .001). In addition, oxygenator dysfunction was increased in the AC+ group (28.9% and 0.00067 events per patient-day, vs AC- 11.1% and 0.00062 events per patient-day; P = .02). Furthermore, the AC+ group received more transfusions: packed red blood cells, AC+ group 94.7% vs AC- group 55.5% (P < .001); fresh frozen plasma, AC+ 60.5% vs AC- 16.6% (P = .001); and platelets, AC+ 84.2% vs AC- 27.7% (P < .001). There was no circuit thrombosis in either groups throughout the duration of ECMO support. CONCLUSIONS: Our results suggest that venovenous ECMO can be safely administered without continuous systemic anticoagulation therapy. This approach may be associated with reduced bleeding diathesis and need for blood transfusions.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kurihara C, Walter JM, Karim A, et al. Feasibility of Venovenous Extracorporeal Membrane Oxygenation Without Systemic Anticoagulation. Ann Thorac Surg. 2020. PMID: 32173339. doi:10.1016/j.athoracsur.2020.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。